AfterRaise/Companies/Neurent Medical

Neurent Medical

€62M Series CRaised 7 months agoIrelandHealthcare & MedtechIreland
Visit website →

Why now

Where Neurent Medical is today

Neurent Medical announced a Series C round of €62M on 12 February 2026, led by MVM Partners.

Latest round
Series C
Amount
€62M
Announced
12 February 2026
Headquarters
Ireland
Sector
Healthcare & Medtech
Growth stage
Series C+
Investors
MVM Partners
Also participating
Sofinnova Partners, and iexisting investors EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners and Enterprise Ireland
Relevant leadership
CEO Brian Shields

Momentum AfterRaise intelligence

AfterRaise Score

48
Steady growth
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
19/25
round size relative to the market
Funding stage
20/20
Series C
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

In their own words

What Neurent Medical says it is doing

Work here? Reserve your page
Market expansionResearch and development

Public signal Read from the company's own description of what the funding supports.

Since the raise

What has happened since

  • 12 February 2026
    €62M Series C
    Led by MVM Partners.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Research programme expansion

Opportunities this could create

  • Provider partnerships
  • Market-entry advisers
  • Local employment infrastructure
  • In-market partnerships
  • Scientific advisers

Based on the Healthcare & Medtech sector, a Series C+ round and the priorities the company itself set out. Not a statement of fact.

Early momentum3 connected signals
  • 12 February 2026€62M Series C announced
  • 12 February 2026Stated priority: market expansion
  • 12 February 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Neurent Medical is open to

Not yet specified

Neurent Medical has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Neurent Medical

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Neurent Medical?

Reserve your company page.

This page was created from publicly available information. When verified company accounts open, your team will be able to correct your profile, tell the market what you actually need and control how people approach you.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every company administrator is verified before access is granted.

The first 1,000 verified funded companies join the Founding 1,000 free for life and keep Founding Company status permanently.

Also moving

Other Healthcare & Medtech companies

See the sector